Stam RW - Search Results

1

D-HPLC analysis of the entire FLT3 gene in MLL rearranged and hyperdiploid acute lymphoblastic leukemia.

Stam RW, den Boer ML, Schneider P, Meier M, Beverloo HB, Pieters R. Stam RW, et al. Haematologica. 2007 Nov;92(11):1565-8. doi: 10.3324/haematol.11220. Haematologica. 2007. PMID: 18024407 Free article.

2

Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia.

Stam RW, den Boer ML, Meijerink JP, Ebus ME, Peters GJ, Noordhuis P, Janka-Schaub GE, Armstrong SA, Korsmeyer SJ, Pieters R. Stam RW, et al. Blood. 2003 Feb 15;101(4):1270-6. doi: 10.1182/blood-2002-05-1600. Epub 2002 Oct 24. Blood. 2003. PMID: 12406912 Free article.

3

Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification.

Armstrong SA, Kung AL, Mabon ME, Silverman LB, Stam RW, Den Boer ML, Pieters R, Kersey JH, Sallan SE, Fletcher JA, Golub TR, Griffin JD, Korsmeyer SJ. Armstrong SA, et al. Among authors: stam rw. Cancer Cell. 2003 Feb;3(2):173-83. doi: 10.1016/s1535-6108(03)00003-5. Cancer Cell. 2003. PMID: 12620411 Free article.

4

Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein.

Stam RW, van den Heuvel-Eibrink MM, den Boer ML, Ebus ME, Janka-Schaub GE, Allen JD, Pieters R. Stam RW, et al. Leukemia. 2004 Jan;18(1):78-83. doi: 10.1038/sj.leu.2403168. Leukemia. 2004. PMID: 14574327

5

Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemia.

Stam RW, den Boer ML, Schneider P, Nollau P, Horstmann M, Beverloo HB, van der Voort E, Valsecchi MG, de Lorenzo P, Sallan SE, Armstrong SA, Pieters R. Stam RW, et al. Blood. 2005 Oct 1;106(7):2484-90. doi: 10.1182/blood-2004-09-3667. Epub 2005 Jun 14. Blood. 2005. PMID: 15956279 Free article.

6

MLL gene rearrangements have no direct impact on Ara-C sensitivity in infant acute lymphoblastic leukemia and childhood M4/M5 acute myeloid leukemia.

Stam RW, Hubeek I, den Boer ML, Buijs-Gladdines JG, Creutzig U, Kaspers GJ, Pieters R. Stam RW, et al. Leukemia. 2006 Jan;20(1):179-82. doi: 10.1038/sj.leu.2404031. Leukemia. 2006. PMID: 16307022 No abstract available.

7

Activating FLT3 mutations in CD4+/CD8- pediatric T-cell acute lymphoblastic leukemias.

Van Vlierberghe P, Meijerink JP, Stam RW, van der Smissen W, van Wering ER, Beverloo HB, Pieters R. Van Vlierberghe P, et al. Among authors: stam rw. Blood. 2005 Dec 15;106(13):4414-5. doi: 10.1182/blood-2005-06-2267. Blood. 2005. PMID: 16326981 Free article. No abstract available.

8

The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia.

Hubeek I, Stam RW, Peters GJ, Broekhuizen R, Meijerink JP, van Wering ER, Gibson BE, Creutzig U, Zwaan CM, Cloos J, Kuik DJ, Pieters R, Kaspers GJ. Hubeek I, et al. Among authors: stam rw. Br J Cancer. 2005 Dec 12;93(12):1388-94. doi: 10.1038/sj.bjc.6602881. Br J Cancer. 2005. PMID: 16333246 Free PMC article.

9

Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymphoblastic leukemia.

Stam RW, den Boer ML, Passier MM, Janka-Schaub GE, Sallan SE, Armstrong SA, Pieters R. Stam RW, et al. Leukemia. 2006 Feb;20(2):264-71. doi: 10.1038/sj.leu.2404074. Leukemia. 2006. PMID: 16357833

10

Towards targeted therapy for infant acute lymphoblastic leukaemia.

Stam RW, den Boer ML, Pieters R. Stam RW, et al. Br J Haematol. 2006 Mar;132(5):539-51. doi: 10.1111/j.1365-2141.2005.05909.x. Br J Haematol. 2006. PMID: 16445826 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters